Variable clinical expression of a Belgian TGFB3 founder variant suggests the presence of a genetic modifier.
Perik MHAM, Govaerts E, Laga S, Goovaerts I, Saenen J, Van Craenenbroeck E, Meester JAN, Luyckx I, Rodrigus I, Verstraeten A, Van Laer L, Loeys BL.
Perik MHAM, et al. Among authors: verstraeten a.
Front Genet. 2023 Aug 31;14:1251675. doi: 10.3389/fgene.2023.1251675. eCollection 2023.
Front Genet. 2023.
PMID: 37719708
Free PMC article.